๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia

โœ Scribed by Federico Pea; Domenico Russo; Mariagrazia Michieli; Massimo Baraldo; Anna Ermacora; Daniela Damiani; Michele Baccarani; Mario Furlanut

Book ID
105993857
Publisher
Springer
Year
2000
Tongue
English
Weight
132 KB
Volume
46
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Kinetics and sensitivity of daunorubicin
Kinetics and sensitivity of daunorubicin in patients with acute leukemia
โœ Michael W. DeGregorio; Walter M. Holleran; Bruce A. Macher; Charles A. Linker; J ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 512 KB

Leukemia cells isolated from eight patients with acute leukemia before treatment were examined for in vitro uptake of daunorubicin (DNR) and inhibition of DNA synthesis. In addition, plasma and cellular levels of DNR and daunorubicinol (DOL) were examined in six of the eight patients. Inhibition of

High-dose liposomal daunorubicin and hig
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
โœ Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB ๐Ÿ‘ 2 views

## Background: Liposomal encapsulation of daunorubicin (daunoxome, dnx; nexstar pharmaceutical, boulder, co) changes the pharmacology profile to increase delivery to tumor sites and decrease toxicity. the authors investigated the effect of daunorubicin in combination with ara-c in patients with ref